Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- FDA-approved regimens (Vasostrict):
- Vasodilatory shock: IV infusion 0.01–0.03 U/min (label cites literature synthesis of 7 septic-shock and 8 post-cardiotomy-shock studies)
- Titrate in 0.005 U/min increments; taper after 8 hours MAP stability without catecholamines
- Central diabetes insipidus (Pitressin): IM/SC 5–10 U, 2–3 times daily